Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$119.35 USD
-0.40 (-0.33%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $119.32 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Price, Consensus and EPS Surprise
ZBH 119.35 -0.40(-0.33%)
Will ZBH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZBH
Why Zimmer (ZBH) is Poised to Beat Earnings Estimates Again
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected to Decline
SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?
Other News for ZBH
Oppenheimer Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases
Disrupting Data Management and E-commerce Strategies with Finch CEO, Lee Roquet
Zeus Names Chief Technology Officer
Best Practices for Developing End-to-End Cloud-Powered Medical Devices, Upcoming Webinar Hosted by Xtalks